vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and INNODATA INC (INOD). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $90.1M, roughly 1.0× INNODATA INC). INNODATA INC runs the higher net margin — 16.5% vs -98.1%, a 114.6% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 54.4%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 66.4%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Innodata Inc., formerly Innodata Isogen, Inc., is an American company that provides business process, technology and consulting services. The company also provides products that aim to help clients create, manage, use and distribute digital information.

HIVE vs INOD — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.0× larger
HIVE
$93.1M
$90.1M
INOD
Growing faster (revenue YoY)
HIVE
HIVE
+164.1% gap
HIVE
218.6%
54.4%
INOD
Higher net margin
INOD
INOD
114.6% more per $
INOD
16.5%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
66.4%
INOD

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
HIVE
HIVE
INOD
INOD
Revenue
$93.1M
$90.1M
Net Profit
$-91.3M
$14.9M
Gross Margin
-27.1%
Operating Margin
Net Margin
-98.1%
16.5%
Revenue YoY
218.6%
54.4%
Net Profit YoY
-234.0%
91.3%
EPS (diluted)
$-0.38
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
INOD
INOD
Q1 26
$90.1M
Q4 25
$93.1M
$72.4M
Q3 25
$87.3M
$62.5M
Q2 25
$45.6M
$58.4M
Q1 25
$58.3M
Q4 24
$29.2M
$59.2M
Q3 24
$22.6M
$52.2M
Q2 24
$32.2M
$32.6M
Net Profit
HIVE
HIVE
INOD
INOD
Q1 26
$14.9M
Q4 25
$-91.3M
$8.8M
Q3 25
$-15.8M
$8.3M
Q2 25
$35.0M
$7.2M
Q1 25
$7.8M
Q4 24
$68.2M
$10.3M
Q3 24
$80.0K
$17.4M
Q2 24
$-18.3M
$-14.0K
Gross Margin
HIVE
HIVE
INOD
INOD
Q1 26
Q4 25
-27.1%
38.3%
Q3 25
4.7%
40.8%
Q2 25
-13.6%
39.4%
Q1 25
39.9%
Q4 24
-43.7%
45.2%
Q3 24
-66.1%
40.8%
Q2 24
-7.4%
28.7%
Operating Margin
HIVE
HIVE
INOD
INOD
Q1 26
Q4 25
15.1%
Q3 25
18.8%
Q2 25
15.3%
Q1 25
14.2%
Q4 24
19.0%
Q3 24
21.9%
Q2 24
1.0%
Net Margin
HIVE
HIVE
INOD
INOD
Q1 26
16.5%
Q4 25
-98.1%
12.2%
Q3 25
-18.1%
13.3%
Q2 25
76.8%
12.4%
Q1 25
13.3%
Q4 24
233.2%
17.4%
Q3 24
0.4%
33.3%
Q2 24
-56.7%
-0.0%
EPS (diluted)
HIVE
HIVE
INOD
INOD
Q1 26
$0.42
Q4 25
$-0.38
$0.26
Q3 25
$-0.07
$0.24
Q2 25
$0.18
$0.20
Q1 25
$0.22
Q4 24
$0.52
$0.35
Q3 24
$0.00
$0.51
Q2 24
$-0.17
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
INOD
INOD
Cash + ST InvestmentsLiquidity on hand
$117.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$128.2M
Total Assets
$624.0M
$210.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
INOD
INOD
Q1 26
$117.4M
Q4 25
$82.2M
Q3 25
$73.9M
Q2 25
$59.8M
Q1 25
$56.6M
Q4 24
$40.5M
$46.9M
Q3 24
$31.7M
$26.4M
Q2 24
$16.5M
Stockholders' Equity
HIVE
HIVE
INOD
INOD
Q1 26
$128.2M
Q4 25
$559.3M
$107.1M
Q3 25
$624.6M
$97.3M
Q2 25
$560.5M
$86.7M
Q1 25
$75.5M
Q4 24
$430.9M
$63.5M
Q3 24
$275.5M
$47.7M
Q2 24
$268.6M
$29.0M
Total Assets
HIVE
HIVE
INOD
INOD
Q1 26
$210.4M
Q4 25
$624.0M
$168.6M
Q3 25
$693.0M
$152.9M
Q2 25
$628.7M
$132.6M
Q1 25
$125.2M
Q4 24
$478.6M
$113.4M
Q3 24
$334.7M
$88.2M
Q2 24
$66.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
INOD
INOD
Operating Cash FlowLast quarter
$46.0M
$37.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.50×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
INOD
INOD
Q1 26
$37.3M
Q4 25
$46.0M
$12.9M
Q3 25
$-10.6M
$18.8M
Q2 25
$10.2M
$4.2M
Q1 25
$10.9M
Q4 24
$-28.5M
$17.2M
Q3 24
$-2.2M
$11.4M
Q2 24
$-4.4M
$-454.0K
Free Cash Flow
HIVE
HIVE
INOD
INOD
Q1 26
Q4 25
$10.1M
Q3 25
$14.5M
Q2 25
$2.5M
Q1 25
$8.5M
Q4 24
$-55.5M
$15.0M
Q3 24
$-34.7M
$9.9M
Q2 24
$-3.2M
FCF Margin
HIVE
HIVE
INOD
INOD
Q1 26
Q4 25
13.9%
Q3 25
23.2%
Q2 25
4.3%
Q1 25
14.6%
Q4 24
-189.9%
25.3%
Q3 24
-153.4%
19.0%
Q2 24
-9.8%
Capex Intensity
HIVE
HIVE
INOD
INOD
Q1 26
Q4 25
3.9%
Q3 25
6.8%
Q2 25
2.9%
Q1 25
4.0%
Q4 24
92.5%
3.7%
Q3 24
143.9%
2.8%
Q2 24
8.4%
Cash Conversion
HIVE
HIVE
INOD
INOD
Q1 26
2.50×
Q4 25
1.46×
Q3 25
2.25×
Q2 25
0.29×
0.59×
Q1 25
1.40×
Q4 24
-0.42×
1.67×
Q3 24
-26.94×
0.65×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons